A comprehensive urinary metabolomic approach for identifying kidney cancerr

Area of Science:

• Urology
• Oncology
• Analytical Chemistry
• Biochemistry

Background:

• Urine contains metabolic signatures ideal for metabolomic analysis, particularly for kidney and urinary system diseases.
• Early cancer detection through urine examination can significantly improve patient outcomes.
• Renal cell carcinoma (RCC) diagnosis can be challenging, necessitating novel detection methods.

Purpose of the Study:

• To evaluate the suitability of three independent analytical techniques for detecting renal cell carcinoma (RCC) in patient urine.
• To explore the potential of urine metabolomics for non-invasive cancer diagnosis.
• To identify potential urinary biomarkers for RCC.

Main Methods:

• Employed hydrophilic interaction chromatography (HILIC-LC-MS), reversed-phase ultra performance liquid chromatography (RP-UPLC-MS), and gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) as complementary separation techniques.
• Utilized urease pretreatment to assess its impact on urine metabolome composition.
• Applied MZmine and XCMS for peak detection and alignment, followed by feature selection, ANOVA, and PLS analysis.

Main Results:

• Detected over 2000 mass spectral features in urine samples.
• Identified significant metabolic components that discriminate between RCC patients and healthy controls, even with a small sample size.
• Reduced significant features to less than 30 components per dataset through feature selection.

Conclusions:

• The combination of analytical techniques effectively covers a broad range of the urine metabolome.
• Urine metabolomics, particularly with advanced analytical methods, shows potential for identifying biomarkers for renal cell carcinoma.
• Further validation in larger cohorts is needed to develop clinically applicable assays for earlier RCC diagnosis and improved patient prognosis.